Trump’s psychedelics push a mixed blessing for neuropsychiatric companies, patients
BioSpace
With a greenlight for ibogaine to enter clinical testing and three unnamed products set to receive Commissioner's National Priority Vouchers this week, it's full speed ahead for psychedelics.
pharminent
April 22, 2026 (Last updated: April 22, 2026)
BioSpace
With a greenlight for ibogaine to enter clinical testing and three unnamed products set to receive Commissioner’s National Priority Vouchers this week, it’s full speed ahead for psychedelics.
